Quality of care in chronic obstructive pulmonary disease;Qualité des soins dans le domaine de la BPCO

Revue des Maladies Respiratoires

Volumn 23, Issue SUPPL. 3, 2006, Pages

  Roche, N ^a  

^a HÔTEL DIEU   (France)

Author keywords

COPD; Diagnosis; Management; Quality; Treatment

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; METHYLXANTHINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DIAGNOSTIC TEST; DISEASE EXACERBATION; HEALTH CARE QUALITY; HUMAN; REVIEW; TREATMENT INDICATION;

CRITICAL PATHWAYS; GUIDELINE ADHERENCE; HEALTH PRIORITIES; HUMANS; INFORMATION DISSEMINATION; PRACTICE GUIDELINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF HEALTH CARE;

EID: 33745984523     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Halbert RJ, Isonaka S, George D, Iqbal A : Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003 ; 123 : 1684-92.
2. Zielinski J, Bednarek M : Early detection of COPD in a high-risk population using spirometric screening. Chest 2001 ; 119 : 731-6.
3. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K : Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003 ; 97 : 115-22.
4. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J : Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997 ; 10 : 822-7.
5. Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, Denish P, Silverman RA, Celedon JC, Reilly JJ, Ginns LC, Speizer FE : Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 ; 162 : 2152-8.
6. Molinié F, Kauffmann F : Epidémiologie descriptive. In: Huchon G, Roche N, eds. Bronchopneumopathies chroniques obstructives. Paris: Editions Margaux Orange ; 2003 : 15-34.
7. Murray CJ, Lopez AD : Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 ; 349 : 1498-504.
8. Detournay B, Pribil C, Fournier M, Housset B, Huchon G, Huas D, Godard P, Voinet C, Chanal I, Jourdanne C, Durand-Zaleski I : The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health 2004 ; 7 : 168-74.
9. Sullivan SD, Ramsey SD, Lee TA : The economic burden of COPD. Chest 2000 ; 117 : 5S-9S.
10. Ruchlin HS, Dasbach EJ : An economic overview of chronic obstructive pulmonary disease. Pharmacoeconomics 2001 ; 19 : 623-42.
11. Strassels SA, Smith DH, Sullivan SD, Mahajan PS : The costs of treating COPD in the United States. Chest 2001 ; 119 : 344-52.
12. Cydulka RK, McFadden ERJ, Emerman CL, Sivinski LD, Pisanelli W, Rimm AA : Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997 ; 156 : 1807-12.
13. Wedzicha JA : Peer review and NICE COPD guidelines. Thorax 2004 ; 59 : 183.
14. Celli BR, Macnee W : Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 ; 23 : 932-46.
15. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS : Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001 ; 163 : 1256-76.
16. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la bronchopneumopathie chronique obstructive. Rev Mal Respir 2003 ; 20 : 294-329.
17. Vergnenègre A : Les recommandations de pratique clinique: un guide de lecture. Rev Mal Respir 2004 ; 21 : S56-S62.
18. Iqbal A, Schloss S, George D, Isonaka S : Worldwide guidelines for chronic obstructive pulmonary disease: a comparison of diagnosis and treatment recommendations. Respirology 2002 ; 7 : 233-9.
19. Lacasse Y, Ferreira I, Brooks D, Newman T, Goldstein RS : Critical appraisal of clinical practice guidelines targeting chronic obstructive pulmonary disease. Arch Intern Med 2001 ; 161 : 69-74.
20. Smith BJ, Hender K, Frith P, Crockett AJ, Cheok F, Spedding S : Systematic assessment of clinical practice guidelines for the management of chronic obstructive pulmonary disease. Respir Med 2003 ; 97 : 37-45.
21. Réseau européen des associations de patients atteints de BPCO : Le manifeste des patients atteints de bronchopneumopathie chronique obstructive. Rev Mal Respir 2003 ; 20 : 471-6.
22. Burgers JS, Cluzeau FA, Hanna SE, Hunt C, Grol R : Characteristics of high-quality guidelines: evaluation of 86 clinical guidelines developed in ten European countries and Canada. Int J Technol Assess Health Care 2003 ; 19 : 148-57.
23. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Rev Mal Respir 2003 ; 20 : S5-S68.
24. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Exacerbations/ décompensations : antibiothérapie. Rev Mal Respir 2003 ; 20 : S65-S68.
25. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Exacerbations/ décompensations : diagnostic, niveau de gravité et prise en charge. Rev Mal Respir 2003 ; 20 : S56-S64.
26. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Traitement chirurgical. Rev Mal Respir 2003 ; 20 : S54-S55.
27. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Oxygénothé rapie et ventilation au long cours. Rev Mal Respir 2003 ; 20 : S50-S53.
28. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Réhabilitation. Rev Mal Respir 2003 ; 20 : S46-S49.
29. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Autres traitements médicamenteux. Rev Mal Respir 2003 ; 20 : S40-S45.
30. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Corticostéroï des. Rev Mal Respir 2003 ; 20 : S36-S39.
31. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Bronchodilatateurs. Rev Mal Respir 2003 ; 20 : S32-S35.
32. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Prévention et réduction des facteurs de risque. Rev Mal Respir 2003 ; 20 : S28-S31.
33. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Diagnostic, niveau de sévérité selon la spirométrie, organisation du suivi. Rev Mal Respir 2003 ; 20 : S21-S27.
34. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Facteurs de risque. Rev Mal Respir 2003 ; 20 : S18-S20.
35. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO.Epidémiologie. Rev Mal Respir 2003 ; 20 : S14-S17.
36. Société de Pneumologie de Langue Française : Recommandations pour la prise en charge de la BPCO. Définition, nosologie et histoire naturelle de la BPCO. Rev Mal Respir 2003 ; 20 : S10-S13.
37. Actualisation 2003 des recommandations de la SPLF sur la prise en charge de la BPCO organisation et argumentaire. Rev Mal Respir 2003 ; 20 : S7-S9.
38. Serrier P : Recommandations sur la BPCO : pourquoi un document spécifique pour les médecins généralistes ? Rev Mal Respir 2003 ; 20 : 679-81.
39. Heffner JE, Ellis R : The guideline approach to chronic obstructive pulmonary disease: how effective? Respir Care 2003 ; 48 : 1257-66.
40. Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP : Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004 ; 98 : 932-37.
41. Decramer M, Bartsch P, Pauwels R, Yernault JC : Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis 2003 ; 59 : 62-80.
42. Fritsch K, Jacot ML, Klarer A, Wick F, Bruggmann P, Krause M, Thurnheer R : Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital. Swiss Med Wkly 2005 ; 135 : 116-21.
43. Huchon GJ, Vergnenegre A, Neukirch F, Brami G, Roche N, Preux PM : Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur Respir J 2002 ; 20 : 806-12.
44. Hoogendoorn M, Feenstra TL, Schermer TR, Hesselink AE, Rutten van Molken MP : Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med 2006 ; 100 : 83-6.
45. Buffels J, Degryse J, Heyrman J, Decramer M : Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Chest 2004 ; 125 : 1394-9.
46. Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ : Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002 ; 324 : 1370.
47. Bolton CE, Ionescu AA, Edwards PH, Faulkner TA, Edwards SM, Shale DJ : Attaining a correct diagnosis of COPD in general practice. Respir Med 2005 ; 99 : 493-500.
48. Walters JA, Hansen E, Mudge P, Johns DP, Walters EH, Wood-Baker R : Barriers to the use of spirometry in general practice. Aust Fam Physician 2005 ; 34 : 201-3.
49. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH : Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999 ; 116 : 416-23.
50. Gorecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J : Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 2003 ; 123 : 1916-23.
51. Tomas LH, Varkey B : Improving health-related quality of life in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2004 ; 10 : 120-7.
52. Roche N, Lepage T, Bourcereau J, Terrioux P : Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 2001 ; 18 : 903-8.
53. Rudolf M : The reality of drug use in COPD: the European perspective. Chest 2000 ; 117 : 29S-32S.
54. Tashkin DP, Cooper CB : The role of long-acting bronchodilators in the management of stable COPD. Chest 2004 ; 125 : 249-59.
55. Morrison D, Skwarski K, Macnee W : Review of the prescription of domiciliary long term oxygen therapy in Scotland. Thorax 1995 ; 50 : 1103-5.
56. Ringbaek TJ, Lange P : The impact of the Danish Oxygen Register on adherence to guidelines for long-term oxygen therapy in COPD patients. Respir Med 2006 ; 100 : 218-25.
57. Jans MP, Schellevis FG, Le Coq EM, Bezemer PD, van Eijk JT : Health outcomes of asthma and COPD patients: the evaluation of a project to implement guidelines in general practice. Int J Qual Health Care 2001 ; 13 : 17-25.
58. Dheda K, Crawford A, Hagan G, Roberts CM : Implementation of British Thoracic Society guidelines for acute exacerbation of chronic obstructive pulmonary disease: impact on quality of life. Postgrad Med J 2004 ; 80 : 169-71.
59. Tinelli C, Rezzani C, Biino G, Marinoni A, Rossi A, Volpini E, Pistorio A, Termini R, Grassi M : Evaluation of the efficacy of the Italian guidelines on COPD: a cluster randomized trial. Monaldi Arch Chest Dis 2003 ; 59 : 199-206.
60. Vestbo J : The TORCH (towards a revolution in COPD health) survival study protocol. Eur Respir J 2004 ; 24 : 206-10.
61. Calverley P : Comprendre les essais cliniques dans la BPCO. Rev Mal Respir 2005 ; 22 : 561-5.
62. Chabot F, Devillier P, Drugeon H, Dusser D, Fournier M, Gaillard J, Grouin JM, Housset B, Huchon G, Leophonte P, Muir JF, Raffy O, Tonnel AB, Tremolieres F, Zuck P, Attali V, Boucot I, Chemali-Hudry J, Daniloski M : Prévention des exacerbations dans la BPCO. Réflexion sur la construction d'une étude clinique évaluant l'effet des corticostéroïdes inhalés. Rev Mal Respir 2004 ; 21 : 685-8.
63. Wijkstra PJ, Guyatt GH, Ambrosino N, Celli BR, Guell R, Muir JF, Prefaut C, Mendes ES, Ferreira I, Austin P, Weaver B, Goldstein RS : International approaches to the prescription of long-term oxygen therapy. Eur Respir J 2001 ; 18 : 909-13.
64. Wagena EJ, Arrindell WA, Wouters EF, Van Schayck CP : Are patients with COPD psychologically distressed? Eur Respir J 2005 ; 26 : 242-8.
65. Yohannes AM, Baldwin RC, Connolly MJ : Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2003 ; 18 : 412-6.
66. Roberts CM, Ryland I, Lowe D, Kelly Y, Bucknall CE, Pearson MG : Audit of acute admissions of COPD: standards of care and management in the hospital setting. Audit Sub-committee of the Standards of Care Committee of the British Thoracic Society and the Clinical Effectiveness and Evaluation Unit at the Royal College of Physicians. Eur Respir J 2001 ; 17 : 343-9.
67. Neill AM, Epton MJ, Martin IR, Drennan CJ, Town GI : An audit of the assessment and management of patients admitted to Christchurch Hospital with chronic obstructive pulmonary disease. N Z Med J 1994 ; 107 : 365-7.
68. Harvey PA, Murphy MC, Dornom E, Berlowitz DJ, Lim WK, Jackson B : Implementing evidence-based guidelines:inpatient management of chronic obstructive pulmonary disease. Intern Med J 2005 ; 35 : 151-5.
69. Roche N, Zureik M, Neukirch F, Perrotin D : L'étude «Urgence BPCO 2003»: évaluation de la prise en charge hospitalière des exacerbations de BPCO. Rev Mal Respir 2004 ; 21 : 117-22.
70. Khoo SM, Lim TK : Prescribing and administration of nebulized bronchodilators: a prospective audit in a university hospital. Respirology 2003 ; 8 : 205-7.
71. Drummond J, Rowe B, Cheung L, Mayers I : The use of noninvasive mechanical ventilation for the treatment of acute exacerbations of chronic obstructive pulmonary disease in Canada. Can Respir J 2005 ; 12 : 129-33.
72. Jimenez PA, Fernandez GJ, Hidalgo RL, Domingo GS, Lara BA, Garcia AJ : Quality of inpatient care and risk of early readmission in acute exacerbation of COPD. An Med Interna 2003 ; 20 : 340-6.
73. Choi PP, Day A, Etchells E : Gaps in the care of patients admitted to hospital with an exacerbation of chronic obstructive pulmonary disease. CMAJ 2004 ; 170 : 1409-13.
74. Durrington HJ, Flubacher M, Ramsay CF, Howard LS, Harrison BD : Initial oxygen management in patients with an exacerbation of chronic obstructive pulmonary disease. QJM 2005 ; 98 : 499-504.
75. Kong GK, Belman MJ, Weingarten S : Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. Chest 1997 ; 111 : 89-94.
76. Brand C, Landgren F, Hutchinson A, Jones C, Macgregor L, Campbell D : Clinical practice guidelines: barriers to durability after effective early implementation. Intern Med J 2005 ; 35 : 162-9.
77. Gore JM, Brophy CJ, Greenstone MA : How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000 ; 55 : 1000-6.
78. Curtis JR, Wenrich MD, Carline JD, Shannon SE, Ambrozy DM, Ramsey PG : Patients' perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. Chest 2002 ; 122 : 356-62.
79. Curtis JR, Engelberg RA, Nielsen EL, Au DH, Patrick DL : Patient-physician communication about end-of-life care for patients with severe COPD. Eur Respir J 2004 ; 24 : 200-5.
80. Knauft E, Nielsen EL, Engelberg RA, Patrick DL, Curtis JR : Barriers and Facilitators to End-of-Life Care Communication for Patients with COPD. Chest 2005 ; 127 : 2188-96.
81. Lacasse Y, Beaudoin L, Rousseau L, Maltais F : Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 2004 ; 61 : 140-7.
82. Poole PJ, Veale AG, Black PN : The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 ; 157 : 1877-80.
83. Garcia-Aymerich J, Escarrabill J, Marrades RM, Monso E, Barreiro E, Anto JM : Differences in COPD care among doctors who control the disease: General practitioner vs. pneumologist. Respir Med 2006 ; 100 : 332-9.
84. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA : Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001 ; 56 : 779-84.
85. Golmohammadi K, Jacobs P, Sin DD : Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung 2004 ; 182 : 187-96.
86. Ouksel H, Gautier V, Bajon D, Barel P, Veale D, Tardif C, Prefaut C, Pison C : La réhbilitation respiratoire à domicile: données de la littérature, aspects pratiques et médico- économiques. Rev Mal Respir 2004 ; 21 : 727-35.
87. Borel JC, Wuyam B, Veale D, Maclet E, Pison C : Mise en œuvre et bilan d'un réentraînement à l'effort à domicile chez 37 patients avec handicap respiratoire. Rev Mal Respir 2004 ; 21 : 711-17.
88. e siècle: service à domicile? Rev Mal Respir 2004 ; 21 : 679-81.
89. Roberts CM, Barnes S, Lowe D, Pearson MG : Evidence for a link between mortality in acute COPD and hospital type and resources. Thorax 2003 ; 58 : 947-9.
90. Cotton MM, Bucknall CE, Dagg KD, Johnson MK, MacGregor G, Stewart C, Stevenson RD : Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Thorax 2000 ; 55 : 902-6.
91. Davies L, Wilkinson M, Bonner S, Calverley PM, Angus RM : "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000 ; 321 : 1265-8.
92. Skwarska E, Cohen G, Skwarski KM, Lamb C, Bushell D, Parker S, Macnee W : Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. Thorax 2000 ; 5 : 907-12.
93. Ram FS, Wedzicha JA, Wright J, Greenstone M : Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence. BMJ 2004 ; 329 : 315.
94. Monninkhof E, van der PJ, Van Herwaarden C, Zielhuis G : Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003 ; 22 : 815-20.
95. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP : Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003 ; 163 : 585-91.
96. Gallefoss F, Bakke PS : Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a 1-year follow-up randomized, controlled trial. Respir Med 2002 ; 96 : 424-31.
97. Foucaud J, Versel M, Laugt O, Taytard A : L'éducation thérapeutique du patient atteint de BPCO : le discours du médecin généraliste : résultats d'une analyse automatique du discours. Rev Mal Respir 2005 ; 22 : 55-62.
98. Plant PK, Owen JL, Elliott MW : Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000 ; 355 : 1931-5.
99. Plant PK, Owen JL, Parrott S, Elliott MW : Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial. BMJ 2003 ; 326 : 956.
100. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr., Kesten S : Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005 ; 127 : 809-17.
101. e Séminaire SPLF d'actualisations. Bronchopneumopathie chronique obstructive. Rev Mal Respir 2004 ; 21 : 845-8.
102. e Séminaire SPLF d'actualisations. Exacerbations et décompensations de BPCO. Rev Mal Respir 2004 ; 21 : 856-9.
103. Godard P : Un plan BPCO ! Pourquoi ? Comment ? Rev Mal Respir 2005 ; 22 : 569-70.